- Report
- November 2024
- 85 Pages
United States
From €3154EUR$3,500USD£2,704GBP
- Report
- February 2024
- 186 Pages
Global
From €4055EUR$4,500USD£3,477GBP
From €3154EUR$3,500USD£2,704GBP
- Report
- July 2024
- 150 Pages
Global
From €3379EUR$3,750USD£2,898GBP
- Report
- July 2024
- 100 Pages
Global
From €3379EUR$3,750USD£2,898GBP
- Report
- July 2024
- 150 Pages
Global
From €3379EUR$3,750USD£2,898GBP
- Report
- July 2024
- 100 Pages
Global
From €3379EUR$3,750USD£2,898GBP
- Report
- August 2023
- 70 Pages
Latin America
From €4280EUR$4,750USD£3,670GBP
- Report
- August 2022
- 96 Pages
Global
From €4501EUR$4,995USD£3,860GBP
- Report
- March 2026
- 200 Pages
Saudi Arabia
From €2513EUR$2,789USD£2,155GBP
- Report
- May 2023
- 140 Pages
Global
From €4459EUR$4,949USD£3,824GBP
- Report
- July 2025
- 250 Pages
Middle East, Africa
From €3486EUR$3,869USD£2,989GBP
- Report
- July 2025
- 250 Pages
Latin America
From €3486EUR$3,869USD£2,989GBP
- Report
- July 2025
- 250 Pages
Asia Pacific
From €3486EUR$3,869USD£2,989GBP
- Report
- July 2025
- 350 Pages
Global
From €4459EUR$4,949USD£3,824GBP
- Report
- July 2025
- 250 Pages
North America
From €3486EUR$3,869USD£2,989GBP
- Report
- July 2025
- 250 Pages
Europe
From €3486EUR$3,869USD£2,989GBP
- Report
- August 2025
- 223 Pages
Global
From €2253EUR$2,500USD£1,932GBP
- Report
- November 2024
- 159 Pages
Global
From €2253EUR$2,500USD£1,932GBP
- Report
- July 2024
- 166 Pages
Global
From €2253EUR$2,500USD£1,932GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more